These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8201677)

  • 1. Results of conservative management of clinically localized prostate cancer.
    Walsh PC
    J Urol; 1994 Jul; 152(1):255-6. PubMed ID: 8201677
    [No Abstract]   [Full Text] [Related]  

  • 2. The Scandinavian Prostate Cancer Group Study: the case for conservative management.
    Parker C
    BJU Int; 2005 Nov; 96(7):952-3. PubMed ID: 16225505
    [No Abstract]   [Full Text] [Related]  

  • 3. Conservative management of clinically-localized prostate cancer.
    Chodak G
    Can J Oncol; 1994 Nov; 4 Suppl 1():20-1; discussion 22-3. PubMed ID: 8853484
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
    Dahm P; Yeung LL; Chang SS; Cookson MS
    J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
    Barocas DA; Cowan JE; Smith JA; Carroll PR;
    J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of watchful waiting for clinically localized prostate cancer.
    Steinberg GD; Bales GT; Brendler CB
    J Urol; 1998 May; 159(5):1431-6. PubMed ID: 9554328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting survival for men with clinically localized prostate cancer: what do we need in contemporary practice?
    Albertsen P
    Cancer; 2008 Jan; 112(1):1-3. PubMed ID: 18000802
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer in Denmark. Incidence, morbidity and mortality.
    Brasso K; Iverson P
    Scand J Urol Nephrol Suppl; 1999; 203():29-33. PubMed ID: 10636567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus statement: the Management of Clinically Localized Prostate Cancer. National Institutes of Health Consensus Development Panel.
    NCI Monogr; 1988; (7):3-6. PubMed ID: 3050539
    [No Abstract]   [Full Text] [Related]  

  • 10. A decision analysis of alternative treatment strategies for clinically localized prostate cancer.
    Walsh PC
    J Urol; 1993 Oct; 150(4):1330-2. PubMed ID: 8371423
    [No Abstract]   [Full Text] [Related]  

  • 11. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
    Adolfsson J; Tribukait B; Levitt S
    Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of localized prostate cancer.
    Clarke NW
    Br J Hosp Med; 1996 Mar 6-19; 55(5):232-3. PubMed ID: 8777510
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome based staging for clinically localized adenocarcinoma of the prostate.
    D'Amico AV; Whittington R; Schultz D; Malkowicz SB; Tomaszewski JE; Wein A
    J Urol; 1997 Oct; 158(4):1422-6. PubMed ID: 9302135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer and life insurance.
    Milano AE
    J Insur Med; 2000; 32(2):96-108. PubMed ID: 15912909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of clinically localized prostate cancer. Part I--observation or treatment?].
    Szelachowska J; Kornafel J; Gisterek I
    Pol Merkur Lekarski; 2006 Dec; 21(126):594-7. PubMed ID: 17405305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
    Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
    CMAJ; 2000 Apr; 162(7):977-83. PubMed ID: 10763395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of prostate cancer.
    Hernandez J; Thompson IM
    Med Clin North Am; 2004 Mar; 88(2):267-79, ix. PubMed ID: 15049578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.
    Tewari A; Divine G; Chang P; Shemtov MM; Milowsky M; Nanus D; Menon M
    J Urol; 2007 Mar; 177(3):911-5. PubMed ID: 17296374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.